000 01167 a2200301 4500
005 20250517151300.0
264 0 _c20181112
008 201811s 0 0 eng d
022 _a1523-6838
024 7 _a10.1053/j.ajkd.2017.02.368
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJun, Min
245 0 0 _aIn Reply to 'International Normalized Ratio Control in Patients With Atrial Fibrillation and CKD'.
_h[electronic resource]
260 _bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_c06 2017
300 _a863-864 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAnticoagulants
650 0 4 _aAtrial Fibrillation
650 0 4 _aHumans
650 0 4 _aInternational Normalized Ratio
650 0 4 _aRenal Insufficiency, Chronic
650 0 4 _aRisk Factors
650 0 4 _aStroke
650 0 4 _aWarfarin
700 1 _aHemmelgarn, Brenda R
773 0 _tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_gvol. 69
_gno. 6
_gp. 863-864
856 4 0 _uhttps://doi.org/10.1053/j.ajkd.2017.02.368
_zAvailable from publisher's website
999 _c27098634
_d27098634